FDA Approves Opioid Agonist Oliceridine

August 07, 2020


The indication limits the new opioid to clinical setting use—no take-home prescriptions.

Opioids Overprescribed After Total Hip or Knee Arthroplasty

August 03, 2020


Policies must change to curb postoperative opioid overprescribing.

FDA Approves Personalized Chronic Pain Therapy Mobile Application

July 23, 2020


The Patient Controller will join a growing list of Abbott digital care products aimed at streamlining the therapeutic experience.

Usual Care Better than Stratified Care for Sciatica

July 21, 2020


The results do not support the transtion from usual care to stratified care for the improvement of sciatica symptoms.

Meloxicam Better than Placebo, CBT for Knee Osteoarthritis

July 20, 2020


Despite negative trial resutls, the data support the posibility of tapering off NSAIDs and the plausibility of self-management approaches like CBT.

Risk Factor Score Could Reduce Gastrointestinal Bleeding Hospitalizations

July 19, 2020


New scoring model is based on an eight-point threshold to accurately predict patients at a low risk of adverse outcomes.

Cannabis and Placebo Similar in Reducing Pain in Sickle Cell Disease Patients

July 17, 2020


The findings suggest cannabis should be further investigated as an alternative to opioids.

FDA Committee Signs Off on Terlipressin for HRS-1

July 16, 2020


The 8-7 decision allows Mallinckrodt to move forward with a Sept. 12 PDUFA date for the investigational agent.

FDA Requests More Non-Clinical Information for HTX-011

June 29, 2020


Heron Therapeutics is expected to meet with the FDA and resubmit an NDA for the post-operative opioid alternative.

Prolonged Opioid Use After Surgery May Burden Public Health

June 26, 2020


It is important to evaluate opioid use among patients before surgery to modify patient-level risk factors.